25.12.2014 Views

2011 Focus Six min walk test .PPT - Foocus

2011 Focus Six min walk test .PPT - Foocus

2011 Focus Six min walk test .PPT - Foocus

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The <strong>Six</strong> Minute Walk Test<br />

What can be learned after just 6 <strong>min</strong>utes<br />

Carl D. Mottram, BA RRT RPFT FAARC<br />

Director - Pulmonary Function Labs and Rehabilitation<br />

Associate Professor of Medicine - Mayo Clinic College of Medicine<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - Background<br />

• 12 <strong>min</strong>ute field<br />

performance <strong>test</strong><br />

• 115 military personnel<br />

• Age: 17-52, mean 22 yrs<br />

• 1 mile flat hard surface<br />

course-mostly running<br />

• Compared the data with<br />

VO 2max<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - Background<br />

• 29 patients with chronic bronchitis<br />

• 12 <strong>min</strong>ute <strong>walk</strong><br />

• level enclosed hospital corridor<br />

• cover as much ground as possible<br />

• Compared O 2max , FVC, FEV 1 , Distance<br />

<strong>walk</strong>ed<br />

McGavin CR et al. BMJ 1 822-3, 1976


<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - Background<br />

• 10 subjects<br />

• 12 <strong>min</strong>ute <strong>walk</strong>s times 5<br />

per subject<br />

• Distance at two <strong>min</strong>ute<br />

intervals<br />

• Conclusion: <strong>Six</strong> <strong>min</strong>ute<br />

<strong>walk</strong> would give you<br />

information without over<br />

tiring subject<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong>- Background<br />

• Guyatt GH<br />

• Control group not<br />

encouraged during <strong>walk</strong><br />

• Encouraged <strong>walk</strong><br />

• Conclusion: Statisically<br />

significant difference inbetween<br />

those subject<br />

encouraged and those<br />

not.<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong><br />

• Advantages • Disadvantages<br />

• Practical and inexpensive • Difficult to assess<br />

• Requires no apparatus effort (e.g. HR, E )<br />

• Adjust own pace and use • Reduced<br />

breathing strategies monitoring<br />

• Walking distance is more<br />

clinically related to ADLs<br />

• Objective & reproducible<br />

outcome measurement


<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - Current Applications<br />

• Exercise tolerance in patients with disease<br />

(functional status)<br />

• Natural history of disease (morbidity and<br />

mortality)<br />

• Pre and post medical intervention comparisons<br />

• Medical intervention<br />

• medication or rehab.<br />

• Surgical intervention (Lung Tx, LVRS)<br />

• Pacemaker<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong><br />

Why was a Standard developed<br />

Coached O 2 & mode HR RPE S PO 2 Hall<br />

McGavin (1976) Y<br />

Mungall (1979) Y<br />

Butland (1982) Y<br />

Guyatt (1984) Y Y<br />

Bernstein (1994) Y Y Y<br />

Cahalin (1995) N Y/N Y Y >80 Y<br />

Cooper J. (1995)<br />

Y/N<br />

Peeters (1996) Y Y Y<br />

Kotloff (1996) N >90<br />

Mayo Y Y/Y Y Y Y Y<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong><br />

Why was a Standard developed<br />

• Intralaboratory<br />

• Useful and cost effective tool in<br />

monitoring exercise tolerance<br />

• Interlaboratory<br />

• Consensus on the protocol


<strong>Six</strong> Minute Mosey<br />

Am J Resp Crit Care Med Vol 166. pp 111–117, 2002<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong><br />

ATS Consensus Statement Am J Respir Crit Care Med Vol 166. pp 111–117, 2002<br />

• Unobstructed level corridor, 30 meters or 100 ft<br />

long or greater<br />

• Start and end of course should be marked with tape<br />

on floor<br />

• Method to measure distance (e.g floor marks etc.)<br />

• Suggest traffic cones at the end of course<br />

• Use of a treadmill not recommended<br />

• Stevens D. Am J Respir Crit Care Med 1999; 160:1540-1543<br />

• Equipment<br />

• Stopwatch, lap counter, Borg scale, chair,<br />

worksheet and pulse oximeter


<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard<br />

• Subject preparation<br />

• Comfortable clothing, light meal, usual<br />

medications<br />

• Pre<strong>test</strong> measurements<br />

• Blood pressure<br />

• ECG within last 6 months, no c/o angina<br />

• Pulse oximetry (optional)<br />

• Use oxygen if appropriate


<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard<br />

• Contraindications<br />

• Absolute<br />

• Unstable coronary disease<br />

• Myocardial infarction within a month<br />

• Relative<br />

• Resting tachycardia > 120 beats/<strong>min</strong><br />

• Systolic BP > 180 mmHg<br />

• Diastolic BP > 100 mmHg<br />

• Syncope with exercise<br />

Salzman Chest 2009<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard<br />

• Safety issues<br />

• Performed in a location where a rapid,<br />

appropriate response to an emergency is<br />

possible – crash cart, medications, phone<br />

• Trained medical staff (RRT, RN, CPFT)<br />

with BLS, although ACLS preferred<br />

• If a patient is on oxygen use their<br />

standard rate or as directed by a<br />

physician or a protocol.<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard


<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard<br />

• Instruct patient to cover as much ground as<br />

possible in the given time<br />

• Coach and give encouragement<br />

• Standard phases of encouragement<br />

• Practice <strong>test</strong>s - controversial<br />

• Document and monitor: O 2 flow, mode of<br />

transport, rest and end-exercise S P O 2<br />

• HR & RPE<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard<br />

• Instruct patient to cover as much ground<br />

as possible in the given time<br />

• Coach and give encouragement<br />

• Standard phases of encouragement<br />

• You are doing well, you have 5 <strong>min</strong>utes to go<br />

• You are doing well, you have 4 <strong>min</strong>utes to go<br />

• You are doing well, youre half way done etc.<br />

• Do not use other words of encouragement<br />

<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - ATSs Standard


<strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> - Report<br />

6-MINUTE WALK<br />

Date Distance Inspired Gas Mode of O2 Transport SpO2 (end exer.) RPE (6-20)<br />

(ft)<br />

5/18/2002 1,173 3.0 L/<strong>min</strong> NC Pt. carried unit 90 17<br />

7/26/2002 1,266 3.0 L/<strong>min</strong> NC Pt. carried unit 94 18<br />

8/15/2002 1,420 2.5 L/<strong>min</strong> Pt. carried unit 92 17<br />

Interpretation<br />

• 117 healthy men and 173 healthy women, aged 40 -80<br />

• The median distance <strong>walk</strong>ed was 576m (1889 ft) for<br />

men and 494m (1620 ft) for women.<br />

• Men = (7.57*ht) – (5.02*age) – 1.76*wt – 309m<br />

• Women = (2.11*ht) – (2.29*wt) – (5.78*age) – 667m<br />

AJRCCM 158; 1384-87 1998


• Minimal clinically important difference<br />

(MCID) for the 6MWT is conservatively<br />

estimated to be 54-80 m (~175-260 ft) using<br />

both distributional and discri<strong>min</strong>ative<br />

methods.<br />

• For an individual patient, the 6MWT would<br />

need to change by about 86 m (280 ft) to be<br />

statistically confident that there has been a<br />

change.<br />

• 460 COPD patients with a<br />

mean FEV1 of 39.2 ±<br />

14.1% predicted and<br />

6MWD of 361 ± 112 m at<br />

baseline.<br />

• Distance should change by<br />

~ 35 m for patients with<br />

moderate to severe COPD<br />

(10% change of baseline)<br />

Eur Respir J 2008; 32: 637–643<br />

Recent Literature


Chest / 135 /5 / May 2009<br />

• Clinical and research role<br />

• Technique<br />

• Coding and reimbursement<br />

Galeazzo IJCOPD August 2009<br />

• 284 patients aged 41 to 86 years (mean age 69.4<br />

years) divided into two groups<br />

• study group (222 patients) undergoing a PR<br />

program<br />

• control group (62 patients) treated only with<br />

drugs.<br />

• 64% had an increase of at least 54 m in the 6MWT<br />

whereas 13% in the control group<br />

• Conclusion: PR is highly effective in improving the<br />

exercise capacity of patients with COPD<br />

• 42 patients post-lung transplant<br />

• 29 performed 6MWT<br />

• Results/Conclusions:<br />

• Patients who <strong>walk</strong>ed > 330 m had a median survival of<br />

1178 days versus 263 days for those who <strong>walk</strong>ed less<br />

• 6MWD provides more accurate prognostic information<br />

than the commonly used FEV1 or changes in the FEV1<br />

over the 3 months post-BOS onset.


• 64 consecutive patients<br />

with advanced NSCLC<br />

• An initial 6MW 400 m<br />

might be a useful<br />

prognostic factor for<br />

survival in patients with<br />

advanced non-small cell<br />

lung cancer.<br />

• 115 PH patients<br />

• Pulmonary arterial<br />

pressure was 49 + 17<br />

mm Hg<br />

• PH patients with a<br />

6MWD 399 m had a<br />

significantly better<br />

prognosis<br />

Med. Sci. Sports Exerc., Vol. 40, No. 10, pp.<br />

1725–1732, 2008<br />

• 9 pts with NYHA Class II–IV PAH who<br />

were stable on 2 months of sildenafil.<br />

• Decreased by 100 meters


• 23 patients with heart failure<br />

• EF 23±7%, were diagnosed as functional class<br />

NYHA II-III<br />

Am Heart J 2009;158:768<br />

• 24 patients with HF and<br />

reduced inspiratory<br />

pressure (MIP < 70% pred)<br />

• Conclusion: The addition of<br />

inspiratory muscle strength<br />

training to aerobic exericse<br />

improves cardiorespiratory<br />

responses to exercise in<br />

selected patients with CHF<br />

and IMW.<br />

• 17 patients with dilated<br />

cardiomyopathy,<br />

moderate to severe<br />

mitral regurgitation, EF<br />

40%, and a 6-<strong>min</strong>ute<br />

<strong>walk</strong> distance between<br />

150 and 450 m were<br />

enrolled


Reimbursement<br />

• AMA-CPT code 94620 – Simple Pulmonary Stress<br />

Test<br />

• Minnesotas CMS 2010 technical - $73.73<br />

Case 1<br />

• 28 y.o. male reports increased shortness<br />

of breath<br />

• Occupation: Works in a<br />

manufacturing job, grinding carbide<br />

• CXR ordered<br />

Case 1<br />

• Hard metal disease is a "giant cell interstitial<br />

pneumonitis" that affects a small <strong>min</strong>ority of<br />

workers who manufacture or use high-speed<br />

tungsten carbide saw tips, drill tips, or discs.<br />

• Exposed to fume or dust from the cobalt<br />

used as a binder in the cemented tungsten<br />

carbide metal. Also known as cobalt lung<br />

• Lung transplant 1 year later<br />

• <strong>Six</strong> <strong>min</strong>ute <strong>walk</strong> data:


Case 1<br />

Case 2<br />

• 64 y.o female with pulmonary fibrosis<br />

• Evaluation for surgery for a elevated<br />

left hemidiaphragm<br />

• PFT and CXR ordered


Case 2<br />

• Pulmonary rehab<br />

ordered to improve<br />

exercise tolerance<br />

Keep on trucking!<br />

Questions

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!